Cargando…
Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906114/ https://www.ncbi.nlm.nih.gov/pubmed/35262832 http://dx.doi.org/10.1007/s10157-022-02203-2 |
| _version_ | 1784665337589923840 |
|---|---|
| author | Toda, Masataro Yoshifuji, Ayumi Kikuchi, Kan Koinuma, Masayoshi Komatsu, Motoaki Fujii, Kentaro Kato, Ai Kikuchi, Takahide Nakazawa, Atsushi Ryuzaki, Munekazu |
| author_facet | Toda, Masataro Yoshifuji, Ayumi Kikuchi, Kan Koinuma, Masayoshi Komatsu, Motoaki Fujii, Kentaro Kato, Ai Kikuchi, Takahide Nakazawa, Atsushi Ryuzaki, Munekazu |
| author_sort | Toda, Masataro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8906114 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89061142022-03-09 Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients Toda, Masataro Yoshifuji, Ayumi Kikuchi, Kan Koinuma, Masayoshi Komatsu, Motoaki Fujii, Kentaro Kato, Ai Kikuchi, Takahide Nakazawa, Atsushi Ryuzaki, Munekazu Clin Exp Nephrol Correction Springer Nature Singapore 2022-03-09 2022 /pmc/articles/PMC8906114/ /pubmed/35262832 http://dx.doi.org/10.1007/s10157-022-02203-2 Text en © The Author(s), under exclusive licence to The Japanese Society of Nephrology 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correction Toda, Masataro Yoshifuji, Ayumi Kikuchi, Kan Koinuma, Masayoshi Komatsu, Motoaki Fujii, Kentaro Kato, Ai Kikuchi, Takahide Nakazawa, Atsushi Ryuzaki, Munekazu Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients |
| title | Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients |
| title_full | Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients |
| title_fullStr | Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients |
| title_full_unstemmed | Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients |
| title_short | Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients |
| title_sort | correction to: factors associated with sars-cov-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906114/ https://www.ncbi.nlm.nih.gov/pubmed/35262832 http://dx.doi.org/10.1007/s10157-022-02203-2 |
| work_keys_str_mv | AT todamasataro correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT yoshifujiayumi correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT kikuchikan correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT koinumamasayoshi correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT komatsumotoaki correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT fujiikentaro correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT katoai correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT kikuchitakahide correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT nakazawaatsushi correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients AT ryuzakimunekazu correctiontofactorsassociatedwithsarscov2antibodytitersandprognosisofbreakthroughinfectioninhemodialysispatients |